Pre-clinical ADME-Tox service provider, Admescope, has acquired a company specialised in the field of metabolic biotransformation research, MetaSafe AB. Read more


Phillips-Medisize has signed a supply agreement for insulin pen components with Sanofi, a leader for diabetes treatment. As a result, injection pen component production at the plant in Kontiolahti, Finland, has been expanded with an automated... Read more


Phillips-Medisize Corporation has announced the start of production and completion of the 6,000 m2 expansion to its Kontiolahti, Finland site. Production has already begun and will continue to ramp up on several new programmes before the first of... Read more